Jonathan Morris
12Patents
4h-index
18Co-inventors
57Inventor score
Filing activity: Jul 11, 2001 → Aug 4, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11180521B2 | Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereof | Human Necessities | 6 | Active |
| US7495000B2 | Variolin derivatives and their use as antitumor agents | Chemistry; Metallurgy | 6 | Expired |
| US7320981B2 | Variolin derivatives as anti-cancer agents | Emerging Cross-Sectional Technologies | 6 | Expired |
| US7772241B2 | Variolin derivatives and their use as antitumor agents | Chemistry; Metallurgy | 5 | Active |
| US10301264B2 | Compounds useful for treating ocular neovasculan | Chemistry; Metallurgy | 1 | Active |
| US9695160B2 | Piperazine derivatives for treating disorders | Emerging Cross-Sectional Technologies | 1 | Active |
| US11420969B2 | SRPK1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10696661B2 | Compounds | Chemistry; Metallurgy | 0 | Active |
| US12325704B2 | SRPK1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9796707B2 | Piperazine derivatives for treating disorders | Emerging Cross-Sectional Technologies | 0 | Active |
| US12024504B2 | 1-methyl-1H-pyrazol-3-yl derivatives for use in the treatment of neovascular diseases | Human Necessities | 0 | Active |
| US9932330B2 | Piperazine derivatives for treating disorders | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.